Authors
Loading...
Experimental treatments improved cerebral blood flow in sickle cell disease by boosting regulatory T cells, suggesting potential immunomodulatory therapies.
Lenhart et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: